Pfizer, Merck strike deal to develop cancer tumor treatment

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 17 November, 2014 by The TZ Newswire Staff

Pfizer, Merck strike deal to develop cancer tumor treatment

Germany’s Merck will get $850 million upfront to work on the product, but Pfizer downgrades its 2014 EPS view as a result of the transaction.
read more

See also
- Next Article London Markets: U.K. stocks fall after Japan GDP shock; AstraZeneca drops
- Previous Article Ancient companies still going strong
Editorial Calender

November 2014

M T W T F S S

1 2

3 4 5 6 7 8 9

10 11 12 13 14 15 16

17 18 19 20 21 22 23

24 25 26 27 28 29 30

« Oct Dec »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 17 November, 2014 by The TZ Newswire Staff

Pfizer, Merck strike deal to develop cancer tumor treatment

See also

Editorial Calender

Recent Tags